CLX
The Clorox Company NYSE Listed Mar 21, 1983$95.80
After hrs
$95.50
-0.31%
Mkt Cap $11.6B
52w Low $84.70
23.5% of range
52w High $132.03
50d MA $95.57
200d MA $108.24
P/E (TTM)
14.6x
EV/EBITDA
10.1x
P/B
24.6x
Debt/Equity
9.0x
ROE
-619.2%
P/FCF
15.6x
RSI (14)
47.70
ATR (14)
$2.76
Beta
0.65
50d MA
$95.57
200d MA
$108.24
Avg Volume
2.7M
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.
1221 Broadway · Oakland, CA 94612-1888 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 1.55 | 1.64 | +5.8% | 96.44 | -5.7% | -9.7% | -0.7% | -0.4% | +4.5% | +2.3% | — |
| Feb 3, 2026 | AMC | 1.43 | 1.39 | -2.8% | 114.98 | -1.0% | +2.4% | -0.1% | +1.5% | +0.2% | +1.6% | — |
| Nov 3, 2025 | AMC | 0.82 | 0.85 | +3.9% | 109.14 | +2.2% | +1.2% | -1.4% | -2.4% | +1.0% | -2.5% | — |
| Jul 31, 2025 | AMC | 2.20 | 2.87 | +30.5% | 125.56 | +1.4% | -2.0% | +0.9% | +1.0% | +0.1% | +0.5% | — |
| May 5, 2025 | AMC | 1.55 | 1.45 | -6.5% | 138.39 | -3.2% | -2.4% | +1.1% | +1.0% | -2.2% | +2.4% | — |
| Feb 3, 2025 | AMC | 1.39 | 1.55 | +11.5% | 159.78 | -3.6% | -7.2% | -1.5% | +1.1% | +0.6% | -0.9% | — |
| Oct 30, 2024 | AMC | 1.41 | 1.86 | +31.9% | 156.51 | +3.4% | +1.3% | +2.9% | -0.4% | -0.0% | +0.2% | — |
| Aug 1, 2024 | AMC | 1.56 | 1.82 | +16.7% | 134.14 | +5.9% | +7.4% | -1.0% | +0.4% | +0.4% | +0.4% | — |
| Apr 30, 2024 | AMC | 1.36 | 1.71 | +25.7% | 147.87 | -5.4% | -5.6% | +0.0% | -1.0% | +0.8% | +1.4% | — |
| Feb 1, 2024 | AMC | 1.08 | 2.16 | +100.0% | 148.04 | +7.1% | +5.6% | -1.2% | +0.2% | +0.5% | -0.8% | — |
| Nov 1, 2023 | AMC | -0.20 | 0.49 | +345.0% | 115.38 | +10.5% | +6.6% | +2.1% | +2.7% | +2.7% | -0.4% | — |
| Aug 2, 2023 | AMC | 1.18 | 1.67 | +41.5% | 152.47 | +6.2% | +9.0% | -1.3% | -0.2% | -1.0% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | JP Morgan | Maintains | Underweight → Underweight | — | $96.44 | $90.99 | -5.7% | -9.7% | -0.7% | -0.4% | +4.5% | +2.3% |
| May 1 | Citigroup | Maintains | Neutral → Neutral | — | $96.44 | $90.99 | -5.7% | -9.7% | -0.7% | -0.4% | +4.5% | +2.3% |
| May 1 | UBS | Maintains | Neutral → Neutral | — | $96.44 | $90.99 | -5.7% | -9.7% | -0.7% | -0.4% | +4.5% | +2.3% |
| May 1 | Evercore ISI | Maintains | Underperform → Underperform | — | $96.44 | $90.99 | -5.7% | -9.7% | -0.7% | -0.4% | +4.5% | +2.3% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $96.44 | $90.99 | -5.7% | -9.7% | -0.7% | -0.4% | +4.5% | +2.3% |
| Apr 23 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $96.85 | $97.44 | +0.6% | +0.8% | +1.0% | -2.0% | -0.1% | -1.9% |
| Apr 21 | Jefferies | Maintains | Buy → Buy | — | $102.17 | $102.31 | +0.1% | -2.5% | -2.8% | +0.8% | +1.0% | -2.0% |
| Apr 17 | JP Morgan | Downgrade | Neutral → Underweight | — | $102.38 | $102.40 | +0.0% | +2.1% | -2.3% | -2.5% | -2.8% | +0.8% |
| Apr 15 | Citigroup | Maintains | Neutral → Neutral | — | $104.44 | $104.32 | -0.1% | -1.5% | -0.5% | +2.1% | -2.3% | -2.5% |
| Apr 15 | Barclays | Maintains | Underweight → Underweight | — | $104.44 | $104.32 | -0.1% | -1.5% | -0.5% | +2.1% | -2.3% | -2.5% |
| Apr 14 | Barclays | Maintains | Underweight → Underweight | — | $103.39 | $103.21 | -0.2% | +1.0% | -1.5% | -0.5% | +2.1% | -2.3% |
| Apr 8 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $103.04 | $105.71 | +2.6% | +2.6% | +1.8% | -2.2% | -1.8% | +1.0% |
| Apr 7 | UBS | Maintains | Neutral → Neutral | — | $104.89 | $104.43 | -0.4% | -1.8% | +2.6% | +1.8% | -2.2% | -1.8% |
| Mar 30 | Deutsche Bank | Maintains | Hold → Hold | — | $102.04 | $101.54 | -0.5% | +0.4% | +1.2% | +0.6% | -3.0% | +3.7% |
| Feb 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $117.77 | $119.00 | +1.0% | -0.1% | +1.5% | +0.2% | +1.6% | +3.7% |
| Feb 4 | Citigroup | Maintains | Neutral → Neutral | — | $114.98 | $113.85 | -1.0% | +2.4% | -0.1% | +1.5% | +0.2% | +1.6% |
| Feb 4 | UBS | Maintains | Neutral → Neutral | — | $114.98 | $113.85 | -1.0% | +2.4% | -0.1% | +1.5% | +0.2% | +1.6% |
| Feb 4 | Evercore ISI | Maintains | Underperform → Underperform | — | $114.98 | $113.85 | -1.0% | +2.4% | -0.1% | +1.5% | +0.2% | +1.6% |
| Feb 4 | JP Morgan | Maintains | Neutral → Neutral | — | $114.98 | $113.85 | -1.0% | +2.4% | -0.1% | +1.5% | +0.2% | +1.6% |
| Jan 23 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $112.20 | $114.23 | +1.8% | +1.1% | -0.5% | +0.3% | -3.9% | +0.8% |
| Jan 16 | JP Morgan | Maintains | Neutral → Neutral | — | $111.23 | $109.96 | -1.1% | -1.1% | -0.1% | +0.6% | +1.5% | +1.1% |
| Jan 14 | UBS | Maintains | Neutral → Neutral | — | $108.86 | $108.91 | +0.0% | +2.3% | -0.2% | -1.1% | -0.1% | +0.6% |
| Jan 8 | TD Cowen | Maintains | Hold → Hold | — | $101.76 | $101.29 | -0.5% | +2.4% | +1.9% | +0.7% | +1.8% | +2.3% |
| Jan 7 | Goldman Sachs | Maintains | Sell → Sell | — | $100.61 | $100.70 | +0.1% | +1.1% | +2.4% | +1.9% | +0.7% | +1.8% |
| Jan 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $100.85 | $100.26 | -0.6% | +0.4% | -0.7% | +1.1% | +2.4% | +1.9% |
| Dec 17 | Citigroup | Maintains | Neutral → Neutral | — | $99.82 | $99.70 | -0.1% | +1.7% | -2.1% | -1.1% | -0.3% | -0.6% |
| Nov 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $109.14 | $111.50 | +2.2% | +1.2% | -1.4% | -2.4% | +1.0% | -2.5% |
| Nov 4 | JP Morgan | Maintains | Neutral → Neutral | — | $109.14 | $111.50 | +2.2% | +1.2% | -1.4% | -2.4% | +1.0% | -2.5% |
| Nov 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $109.14 | $111.50 | +2.2% | +1.2% | -1.4% | -2.4% | +1.0% | -2.5% |
| Nov 4 | Citigroup | Maintains | Neutral → Neutral | — | $109.14 | $111.50 | +2.2% | +1.2% | -1.4% | -2.4% | +1.0% | -2.5% |
| Oct 10 | JP Morgan | Maintains | Neutral → Neutral | — | $120.00 | $120.18 | +0.1% | +0.1% | +0.2% | -0.9% | -0.8% | -0.6% |
| Oct 9 | Citigroup | Maintains | Neutral → Neutral | — | $119.59 | $119.59 | +0.0% | +0.3% | +0.1% | +0.2% | -0.9% | -0.8% |
| Oct 8 | BofA Securities | Maintains | Neutral → Neutral | — | $120.49 | $119.87 | -0.5% | -0.7% | +0.3% | +0.1% | +0.2% | -0.9% |
| Oct 8 | UBS | Maintains | Neutral → Neutral | — | $120.49 | $119.87 | -0.5% | -0.7% | +0.3% | +0.1% | +0.2% | -0.9% |
| Oct 1 | Barclays | Maintains | Underweight → Underweight | — | $123.30 | $122.93 | -0.3% | -0.5% | -0.4% | +0.8% | -3.7% | +1.5% |
| Sep 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $123.08 | $123.68 | +0.5% | -0.3% | +1.4% | -1.1% | +0.3% | -0.5% |
| Sep 8 | JP Morgan | Maintains | Neutral → Neutral | — | $127.03 | $126.73 | -0.2% | -0.9% | -0.2% | -1.9% | +0.9% | -0.7% |
| Sep 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $124.63 | $124.50 | -0.1% | +1.9% | -0.9% | -0.2% | -1.9% | +0.9% |
| Aug 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $125.56 | $127.26 | +1.4% | -2.0% | +0.9% | +1.0% | +0.1% | +0.5% |
| Aug 1 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $125.56 | $127.26 | +1.4% | -2.0% | +0.9% | +1.0% | +0.1% | +0.5% |
| Jul 25 | JP Morgan | Maintains | Neutral → Neutral | — | $131.42 | $131.45 | +0.0% | -0.5% | -2.7% | -0.2% | -0.7% | -0.5% |
| Jul 17 | UBS | Maintains | Neutral → Neutral | — | $126.90 | $126.90 | +0.0% | +1.9% | -0.7% | -1.4% | +2.5% | +1.3% |
| Jul 15 | Citigroup | Maintains | Neutral → Neutral | — | $127.40 | $126.84 | -0.4% | -2.5% | +2.2% | +1.9% | -0.7% | -1.4% |
| Jul 15 | Barclays | Maintains | Underweight → Underweight | — | $127.40 | $126.84 | -0.4% | -2.5% | +2.2% | +1.9% | -0.7% | -1.4% |
| Jul 9 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $125.96 | $126.00 | +0.0% | +0.0% | +1.5% | -1.0% | +0.7% | -2.5% |
| Jun 26 | Jefferies | Maintains | Buy → Buy | — | $119.48 | $119.67 | +0.2% | -1.2% | +1.0% | +0.8% | +2.9% | +0.9% |
| May 7 | Barclays | Maintains | Underweight → Underweight | — | $135.05 | $135.05 | +0.0% | +1.1% | +1.0% | -2.2% | +2.4% | -1.3% |
| May 6 | JP Morgan | Maintains | Neutral → Neutral | — | $138.39 | $134.00 | -3.2% | -2.4% | +1.1% | +1.0% | -2.2% | +2.4% |
| May 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $138.39 | $134.00 | -3.2% | -2.4% | +1.1% | +1.0% | -2.2% | +2.4% |
| May 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $138.39 | $134.00 | -3.2% | -2.4% | +1.1% | +1.0% | -2.2% | +2.4% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Breber Pierre RDir | — | Buy | 5,000 | $85.82 | $429K | 18,000 | +4.52% | +0.24% |
8-K · 8.01
!! High
The Clorox Company -- 8-K 8.01: Material Event / Announcement
May 11
8-K · 7.01
! Medium
The Clorox Company -- 8-K 7.01: Regulation FD Disclosure
Apr 30
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Clorox's acquisition of GOJO expands its product portfolio across disinfection and hygiene categories, potentially boosting revenue growth and margin synergies while strengthening competitive positioning against larger rivals.
Apr 1
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
Clorox secured new short-term financing flexibility for operational needs, indicating management confidence in near-term cash flow while adding leverage that could constrain future financial flexibility if unutilized.
Mar 10
8-K · 7.01
! Medium
Clorox Company -- 8-K 7.01: Regulation FD Disclosure
Clorox disclosed material information to investors via Regulation FD, signaling potential guidance updates or strategic announcements that could impact stock valuation and should be monitored for earnings implications.
Feb 3
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 7,850,437 | $814M | New | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 5,784,592 | $599M | New | Mar 2026 |
| 3 | Invesco Ltd. | 4,859,240 | $504M | — | Mar 2026 |
| 4 | Morgan Stanley | 4,586,302 | $462M | Reduced | Dec 2025 |
| 5 | Point72 Asset Management | 1,592,288 | $165M | Added | Mar 2026 |
| 6 | Northern Trust Corp | 1,591,829 | $165M | Added | Mar 2026 |
| 7 | Proshare Advisors Llc | 1,515,910 | $157M | Added | Mar 2026 |
| 8 | Fmr Llc | 1,469,115 | $152M | Added | Mar 2026 |
| 9 | Citadel Advisors Llc | 1,426,468 | $148M | — | Mar 2026 |
| 10 | Royal Bank Of Canada | 1,418,204 | $147M | Added | Mar 2026 |
| 11 | Bank Of America Corp /de/ | 1,405,774 | $146M | Reduced | Mar 2026 |
| 12 | Bank Of New York Mellon Corp | 1,280,226 | $133M | Added | Mar 2026 |
| 13 | Aqr Capital Management Llc | 1,069,972 | $108M | Added | Mar 2026 |
| 14 | Confluence Investment Management Llc | 932,575 | $97M | New | Mar 2026 |
| 15 | Ubs Group Ag | 914,364 | $95M | Added | Mar 2026 |
| 16 | Amundi | 747,780 | $77M | New | Mar 2026 |
| 17 | Arrowstreet Capital, Limited Partnership | 727,015 | $75M | Reduced | Mar 2026 |
| 18 | Millennium Management | 691,847 | $72M | — | Mar 2026 |
| 19 | Jpmorgan Chase & Co | 697,247 | $71M | Added | Mar 2026 |
| 20 | Wells Fargo & Company/mn | 633,542 | $66M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$11.58B
Enterprise Value
$14.12B
P/E (TTM)
14.57x
Forward P/E
16.33x
PEG Ratio
0.10x
P/B
24.55x
P/S
1.68x
P/FCF
15.65x
EV/EBITDA
10.10x
Shares Out
124.3M
Financials (TTM)
Revenue
$7.10B
Net Income
$810.0M
EBITDA
$1.40B
Free Cash Flow
$761.0M
Op Cash Flow
$981.0M
EPS Basic
$6.56
EPS Diluted
$6.52
EPS Forward
$5.87
Gross Margin
45.0%
Op Margin
16.6%
Net Margin
11.4%
Balance Sheet
Total Assets
$5.56B
Total Liab.
$5.08B
Total Equity
$482.0M
Cash
$167.0M
LT Debt
$2.48B
Book Value/Sh
$3.90
Debt/Equity
8.97x
Current Ratio
0.84
Quick Ratio
0.57
Returns & Growth
ROE
-619.2%
ROA
13.8%
ROIC
24.1%
Rev Growth YoY
+0.2%
EPS Growth YoY
+191.6%
Price Returns
2W
-1.3%
1M
-6.7%
3M
-29.2%
6M
-16.6%
12M
-31.7%
Technicals
52W High
$132.03
52W Low
$84.70
50d MA
$95.57
200d MA
$108.24
RSI (14)
47.70
ATR (14)
$2.76
Beta
0.65
Avg Volume
2.7M
Dividends
Div Rate
$4.87
Div Yield
5.6%
Frequency
4
Ex-Div Date
Apr 22, 2026
Analyst Price Targets
Consensus
$117.33
High
$139.00
Low
$94.00
Median
$117.00
Data updated apr 25, 2026 1:51am
· Source: financialmodelingprep.com